NCT05114421 2025-08-07
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Interventional × High Grade Fallopian Tube Serous Adenocarcinoma × Clear all